Guolian Minsheng Receives CSRC No-Objection Letter for Up to RMB 2 Billion Capital Injection into Hong Kong Subsidiary

Stock News

Yesterday

Guolian Minsheng (01456) has announced that it recently received a reply letter from the China Securities Regulatory Commission (CSRC) regarding the company's capital injection into its Hong Kong subsidiary.

The reply letter, numbered 1429 (2026) from the CSRC's Institutional Department, stated that the regulator has no objection to the company injecting up to RMB 2 billion into Guolian Hong Kong.

The company will carry out the relevant procedures in accordance with the requirements of the reply letter and the relevant regulations of the State Administration of Foreign Exchange.

The capital injection into Guolian Hong Kong is still subject to the completion of overseas investment project filing procedures before it can be implemented.

After the capital injection is completed, the company will, within 10 working days, submit the relevant regulatory approval documents for the change of registration of Guolian Hong Kong to the Jiangsu Securities Regulatory Bureau.

The company will strictly use the relevant funds in accordance with the capital injection purposes reported to the CSRC and will not change the purpose of the capital injection.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/news/1160306965"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1160306965\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1160306965?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-30 17:49","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1160306965","market":"sh","top_or_hot":-1,"title":"Guolian Minsheng Receives CSRC No-Objection Letter for Up to RMB 2 Billion Capital Injection into Hong Kong Subsidiary","media":"Stock News","content":"<p>Guolian Minsheng (01456) has announced that it recently received a reply letter from the China Securities Regulatory Commission (CSRC) regarding the company's capital injection into its Hong Kong subsidiary.<br><br>The reply letter, numbered 1429 (2026) from the CSRC's Institutional Department, stated that the regulator has no objection to the company injecting up to RMB 2 billion into Guolian Hong Kong.<br><br>The company will carry out the relevant procedures in accordance with the requirements of the reply letter and the relevant regulations of the State Administration of Foreign Exchange.<br><br>The capital injection into Guolian Hong Kong is still subject to the completion of overseas investment project filing procedures before it can be implemented.<br><br>After the capital injection is completed, the company will, within 10 working days, submit the relevant regulatory approval documents for the change of registration of Guolian Hong Kong to the Jiangsu Securities Regulatory Bureau.<br><br>The company will strictly use the relevant funds in accordance with the capital injection purposes reported to the CSRC and will not change the purpose of the capital injection.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Guolian Minsheng Receives CSRC No-Objection Letter for Up to RMB 2 Billion Capital Injection into Hong Kong Subsidiary</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGuolian Minsheng Receives CSRC No-Objection Letter for Up to RMB 2 Billion Capital Injection into Hong Kong Subsidiary\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-09-30 17:49</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Guolian Minsheng (01456) has announced that it recently received a reply letter from the China Securities Regulatory Commission (CSRC) regarding the company's capital injection into its Hong Kong subsidiary.<br><br>The reply letter, numbered 1429 (2026) from the CSRC's Institutional Department, stated that the regulator has no objection to the company injecting up to RMB 2 billion into Guolian Hong Kong.<br><br>The company will carry out the relevant procedures in accordance with the requirements of the reply letter and the relevant regulations of the State Administration of Foreign Exchange.<br><br>The capital injection into Guolian Hong Kong is still subject to the completion of overseas investment project filing procedures before it can be implemented.<br><br>After the capital injection is completed, the company will, within 10 working days, submit the relevant regulatory approval documents for the change of registration of Guolian Hong Kong to the Jiangsu Securities Regulatory Bureau.<br><br>The company will strictly use the relevant funds in accordance with the capital injection purposes reported to the CSRC and will not change the purpose of the capital injection.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"601456","symbol_name":"国联民生","start_time":0,"source_url":"","article_id":"1160306965","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1160306965","pubTimestamp":1790761743,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Guolian Minsheng (01456) has announced that it recently received a reply letter from the China Securities Regulatory Commission (CSRC) regarding the company's capital injection into its Hong Kong...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"601456":"国联民生","BK0276":"资本市场","01456":"国联民生","BK1147":"投资银行业与经纪业","BK1564":"中资券商股"},"translate_title":"国联民生收到中国证监会关于向香港子公司注资高达20亿元人民币的无异议函","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"601456":1,"01456":1},"content_text":"Guolian Minsheng (01456) has announced that it recently received a reply letter from the China Securities Regulatory Commission (CSRC) regarding the company's capital injection into its Hong Kong subsidiary.The reply letter, numbered 1429 (2026) from the CSRC's Institutional Department, stated that the regulator has no objection to the company injecting up to RMB 2 billion into Guolian Hong Kong.The company will carry out the relevant procedures in accordance with the requirements of the reply letter and the relevant regulations of the State Administration of Foreign Exchange.The capital injection into Guolian Hong Kong is still subject to the completion of overseas investment project filing procedures before it can be implemented.After the capital injection is completed, the company will, within 10 working days, submit the relevant regulatory approval documents for the change of registration of Guolian Hong Kong to the Jiangsu Securities Regulatory Bureau.The company will strictly use the relevant funds in accordance with the capital injection purposes reported to the CSRC and will not change the purpose of the capital injection.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}